INTRALUMINAL BRACHYTHERAPY IN LOCO-REGIONAL RECURRENT ADVANCEDESOPHAGEAL CARCINOMA / 中华放射肿瘤学杂志

From May 1990 January 1991, 22 patients with recurrent esophageal carcinoma after external radiotherapy were treated by intraluminal brachytherapy of Iridium-192(HDR). Preliminary results showed relief of symptoms and improvment of general condition with gain weight. Barium X-ray films revealed better barium passage and smooth mucosa in 80% patients. 14 cases have survived over 8 months and 2 over 16 months. The average survival was 9.18 months.